2m 2m 2m 2m 2m 2m 2m
AMYLYX PHARM (AMLX)
NASDAQ
$30.83-$0.98 (-3.07%)
Price as of Nov 12, 2026 9:34 AM EST- $4.1BMarket Cap
- 157.91%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AMYLYX PHARM (AMLX)
$30.83-$0.98 (-3.07%)
AMLX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $31.80 | ||
Change | +$0.89 (+2.88%) | ||
Open | $31.16 | ||
High | $31.88 | ||
Low | $30.46 | ||
Previous Close | $30.91 | ||
Volume | 2,001,377 | ||
30-Day Average Volume | 1,332,187 | ||
1-Week Change | 8.16% | ||
1-Month Change | 13.01% | ||
1-Year Change | 157.91% | ||
3-Year Change | 154.81% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 128.6M | ||
Total Assets | $786.8M | ||
Market Cap | $4.1B | ||
Enterprise Value | $3.8B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$45.5M | ||
Free Cash Flow | -$33.7M | ||
EBIT | -$45.5M | ||
EBITDA | -$45.5M | ||
Net Working Capital | $749.8M | ||
EPS | -$0.38 | ||
Enterprise Value/EBITDA | -85 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -84 | ||
PEG | -33 | ||
Price/Free Cash Flow | -121 | ||
Price/Operating Cash Flow | -121 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 03/28/2018 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue